A detailed history of Sg Americas Securities, LLC transactions in Macrogenics Inc stock. As of the latest transaction made, Sg Americas Securities, LLC holds 16,822 shares of MGNX stock, worth $54,335. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16,822
Holding current value
$54,335
% of portfolio
0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 03, 2024

BUY
$3.0 - $5.55 $50,466 - $93,362
16,822 New
16,822 $55,000
Q4 2023

Jan 12, 2024

BUY
$4.48 - $10.11 $34,549 - $77,968
7,712 Added 36.94%
28,589 $275,000
Q3 2023

Oct 13, 2023

BUY
$4.48 - $6.19 $93,528 - $129,228
20,877 New
20,877 $97,000
Q4 2022

Feb 02, 2023

SELL
$3.34 - $6.98 $12,879 - $26,914
-3,856 Reduced 12.24%
27,635 $185,000
Q3 2022

Oct 31, 2022

SELL
$3.01 - $5.22 $33,757 - $58,542
-11,215 Reduced 26.26%
31,491 $109,000
Q2 2022

Jul 29, 2022

BUY
$2.25 - $9.99 $96,088 - $426,632
42,706 New
42,706 $126,000
Q1 2022

Apr 29, 2022

SELL
$8.12 - $16.9 $136,407 - $283,903
-16,799 Closed
0 $0
Q4 2021

Feb 07, 2022

SELL
$15.91 - $21.88 $235,547 - $323,933
-14,805 Reduced 46.85%
16,799 $270,000
Q3 2021

Nov 01, 2021

BUY
$19.74 - $28.7 $456,902 - $664,290
23,146 Added 273.66%
31,604 $662,000
Q2 2021

Aug 12, 2021

SELL
$20.49 - $35.63 $178,283 - $310,016
-8,701 Reduced 50.71%
8,458 $227,000
Q1 2021

May 13, 2021

SELL
$18.99 - $33.2 $11,090 - $19,388
-584 Reduced 3.29%
17,159 $547,000
Q4 2020

Feb 04, 2021

BUY
$19.41 - $26.0 $31,657 - $42,406
1,631 Added 10.12%
17,743 $406,000
Q3 2020

Nov 09, 2020

SELL
$24.69 - $31.6 $194,581 - $249,039
-7,881 Reduced 32.85%
16,112 $406,000
Q2 2020

Jul 20, 2020

BUY
$5.2 - $29.12 $48,542 - $271,835
9,335 Added 63.69%
23,993 $670,000
Q1 2020

Apr 30, 2020

BUY
$4.28 - $12.11 $62,736 - $177,508
14,658 New
14,658 $85,000
Q2 2018

Aug 07, 2018

SELL
$19.78 - $24.67 $93,302 - $116,368
-4,717 Closed
0 $0
Q1 2018

May 03, 2018

BUY
$18.89 - $32.46 $89,104 - $153,113
4,717 New
4,717 $119,000
Q4 2017

Jan 24, 2018

SELL
$16.19 - $20.3 $155,148 - $194,534
-9,583 Closed
0 $0
Q3 2017

Nov 07, 2017

BUY
$15.52 - $18.94 $148,728 - $181,502
9,583
9,583 $177,000

Others Institutions Holding MGNX

About MACROGENICS INC


  • Ticker MGNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 61,458,800
  • Market Cap $199M
  • Description
  • MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...
More about MGNX
Track This Portfolio

Track Sg Americas Securities, LLC Portfolio

Follow Sg Americas Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.